• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inhibrx Biosciences, Inc. - Common Stock (NQ:INBX)

96.99 -0.94 (-0.96%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 201,448
Open 99.30
Bid (Size) 96.44 (400)
Ask (Size) 96.99 (100)
Prev. Close 97.93
Today's Range 96.07 - 100.12
52wk Range 28.16 - 155.29
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup ↗
October 02, 2026
Inhibrx Biosciences' CEO bought $3.6 million in shares after strong Phase 2 data, as insiders accumulate stock amid heavy short interest and an upcoming FDA decision on ozekibart. 
Via MarketBeat
News headline image
Inhibrx Founder and CEO Mark Lappe Buys 25,000 Shares for $2.6 Million. What Does His Confidence Tell Investors? ↗
September 15, 2026
Lappe's purchase through family trusts boosts his beneficial ownership to 950,000 shares, or 6% of outstanding equity, as Inhibrx trades near $114 following a 293% gain over the past year. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

52-Week Range 37.5% below 52-week high
96.99
28.1652W Low 155.2952W High
1 Week 10.1% below 1-week high
96.071W Low 107.901W High

Inhibrx Biosciences, Inc. - Common Stock (INBX) traded between $28.16 and $155.29 over the past 52 weeks and last traded at $96.99, 37.5% below its 52-week high. Over the past week it ranged between $96.07 and $107.90.

Past 12 Months
-4.6%
-22.4%
-0.2%
+52.2%
+29.3%
+176.6%
1W -$4.72
1M -$27.98
3M -$0.15
6M +$33.27
YTD +$21.95
1Y +$61.92

INBX was +176.6% over the past year, +52.2% over six months, +29.3% year to date, -4.6% in the last week.

12 Months vs Market
INBX
+176.6%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months INBX returned +176.6% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.66× 3-mo avg
Today 201,448 3-mo avg 305.9K
1W
247.4K
1M
344.0K
3M
305.9K
6M
377.3K
YTD
317.8K
1Y
338.7K

INBX most recently traded 201,448 shares against a 3-month average daily volume of 305.9K.

More News

Read More
There are notable gap-ups and gap-downs in today's session. ↗
September 08, 2026
Via Chartmill
News headline image
Inhibrx Biosciences’ INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study ↗
May 11, 2026
Via MarketBeat
Why Is INBX Stock Rising Today? ↗
October 24, 2025
Via Stocktwits
Top movers in Wednesday's session ↗
April 22, 2026
Via Chartmill
These stocks are moving in today's session ↗
April 22, 2026
Via Chartmill
Which stocks are gapping on Wednesday? ↗
April 22, 2026
Via Chartmill
Which stocks are moving before the opening bell on Wednesday? ↗
April 22, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 14, 2025 ↗
November 14, 2025
Via Benzinga
News headline image
Unusual volume stocks in Thursday's session ↗
October 30, 2025
Via Chartmill
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
October 28, 2025
Via Chartmill
News headline image
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone ↗
October 27, 2025
Via Benzinga
Topics Economy
News headline image
Inhibrx Biosciences Soars Over 90% on Breakthrough Rare Bone Cancer Trial Results
October 24, 2025
Via MarketMinute
News headline image
Here are the top movers in Friday's session. ↗
October 24, 2025
Via Chartmill
News headline image
Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday? ↗
October 24, 2025
Via Benzinga
Topics Economy
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 24, 2025
Via Benzinga
News headline image
What's going on in today's session ↗
October 24, 2025
Via Chartmill
News headline image
Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October ↗
October 24, 2025
Via Benzinga
Topics Stocks
News headline image
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
October 24, 2025
Via MarketMinute
News headline image
Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday ↗
October 24, 2025
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
October 24, 2025
Via Chartmill
News headline image
Get insights into the top gainers and losers of Friday's pre-market session. ↗
October 24, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 24, 2025
Via Benzinga
News headline image
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
October 24, 2025
Via Benzinga

Frequently Asked Questions

Is Inhibrx Biosciences, Inc. - Common Stock publicly traded?
Yes, Inhibrx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Inhibrx Biosciences, Inc. - Common Stock trade on?
Inhibrx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibrx Biosciences, Inc. - Common Stock?
The ticker symbol for Inhibrx Biosciences, Inc. - Common Stock is INBX on the Nasdaq Stock Market
What is the current price of Inhibrx Biosciences, Inc. - Common Stock?
The current price of Inhibrx Biosciences, Inc. - Common Stock is 96.99
When was Inhibrx Biosciences, Inc. - Common Stock last traded?
The last trade of Inhibrx Biosciences, Inc. - Common Stock was at 10/02/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap